netFormulary
 Report : A-Z NHS England items in Formulary 17/06/2021 00:41:51
[Back]
 
Section Status NHS England Name
08.03.04.01 Formulary MHS England Abemaciclib Verzenios®
08.01.05 Formulary MHS England Alectinib Alecensa®
08.01.05 Formulary MHS England Atezolizumab 
08.01.05 Formulary MHS England Avelumab  Bavencio ®
08.01.05 Formulary MHS England Axicabtagene ciloleucel 
03.04.02 Formulary MHS England Benralizumab Fasenra®
08.01.05 Formulary MHS England Brentuximab vedotin Adcetris®
08.01.05 Formulary MHS England Brigatinib Alunbrig®
08.01.05 Formulary MHS England Cabozantinib 
04.06 Formulary MHS England Cannabidiol  Epidyolex®
09.01.04 Formulary MHS England Caplacizumab Cablivi®
08.01.05 Formulary MHS England Carfilzomib Kyrolis®
08.01.05 Formulary MHS England Dacomitinib Vizimpro®
08.01.05 Formulary MHS England Daratumumab Darzalex ®
08.03.04.02 Formulary MHS England Darolutamide Nubeqa®
08.01.03 Formulary MHS England Daunorubicin/ cytarabine Vyxeos
08.02.04 Formulary MHS England Dinutuximab beta Qarziba®
08.01.05 Formulary MHS England Encorafenib Braftovi®
08.01.05 Formulary MHS England Entrectinib 
08.01.05 Formulary MHS England Gilteritinib (as fumarate) 
08.01.05 Formulary MHS England Inotuzumab ozogamicin Besponsa®
08.02.03 Formulary MHS England Isatuximab Sarcusa®
05.03 Formulary MHS England Letermovir 
08.01.05 Formulary MHS England Lorlatinib 
08.01.05 Formulary MHS England Midostaurin Rydapt ®
08.02.03 Formulary MHS England Ocrelizumab Ocrevus®
08.01.05 Formulary MHS England Olaparib 
08.01.05 Formulary MHS England Osimertinib 
08.01.05 Formulary MHS England Pablociclib Ibrance®
08.01.05 Formulary MHS England Polatuzumab vedotin 
08.02.04 Formulary MHS England Siponimod Mayzent®
08.01.05 Formulary MHS England Tisagenlecleucel Kymriah®
08.01.01 Formulary MHS England Treosulfan 
08.01.05 Formulary MHS England Venetoclax Venclyxto®
Sunderland Joint Formulary